Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection

摘要

BACKGROUNDHepatitis E virus (HEV) infection is a cause of chronic hepatitis in immunosuppressed patients. Sustained virologic response rates to a 12-wk course of ribavirin therapy were reported to be > 70% in the West. This study describes the outcome of HEV treatment in a transplant center in Singapore.